Chengdu Seamaty Technology Co., Ltd

What Chengdu Seamaty Technology Co., Ltd does

Chengdu Seamaty Technology Co., Ltd (成都斯马特科技股份有限公司) is a Chengdu-based point-of-care testing (POCT) in vitro diagnostics company founded on August 30, 2012, with current global headcount of 620+ across eleven-plus wholly-owned subsidiaries. The company designs and manufactures microfluidic disc-based biochemical, chemiluminescence immunoassay, blood gas electrolyte, blood cell, and molecular (qPCR) analyzers, paired with single-use freeze-dried reagent discs that have a one-year shelf life at 2-8°C storage. Its technology platform integrates blood sampling, separation, dilution, reaction, and detection onto a single microfluidic disc, supported by what the company describes as the world's first capillary chemiluminescence detection platform and proprietary rare-earth nanocrystal fluorescence immunoassay chemistry.

Seamaty's product portfolio serves two principal end markets. The veterinary line (SMT-120VP, V7, Qt3, MiniLabVet, VG2, VQ1) targets companion-animal clinics, exotic-pet hospitals, livestock operations, and aquaculture farms, achieving over 40% coverage of China's domestic pet hospital market and a presence across 15,000+ veterinary hospitals worldwide. The medical line (SD1, SD2, SMT-120Pro, SG1, SMT-680, SMT-780) addresses primary care clinics, community health centers, emergency departments, ICUs, ambulances, and rural township hospitals. Reagent disc variants cover 39 medical and 13 veterinary test combinations. The company holds 114 intellectual property rights including 2 international PCT patents, with certifications including EU CE Marking, TÜV ISO 13485:2016 (for both parent and reagent subsidiary Pulitai), and multiple Chinese provincial and national recognitions.

The business model combines one-time instrument sales with a high-margin recurring consumables stream tied to installed analyzers, supplemented by technical support and after-sales services. Go-to-market mixes a domestic Chinese distributor network covering 23 provinces and 283 cities with eight wholly-owned overseas subsidiaries (Germany, Russia, Thailand, Singapore, Turkey, Egypt, Brazil), reaching customers in 150+ countries; export sales represent approximately 55% of total revenue. Reported revenue growth exceeded 50% YoY in 2023, supported by ongoing capacity expansion (an 82-mu, 130,000 sqm Chengdu Eastern New Area manufacturing base planned for phased 2024-2026 completion) and preparations for an initial public offering following the late-2023 conversion to a joint-stock company structure.

Name

Chengdu Seamaty Technology Co., Ltd

Legal name

成都斯马特科技股份有限公司

Website

https://seamaty.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Chengdu Seamaty Technology is a Chinese POCT in vitro diagnostics firm specializing in microfluidic disc-based analyzers for veterinary and human medical use. It serves 15,000+ veterinary hospitals globally and ~40% of China's pet hospitals, with ~55% of revenue from exports.

Ownership category

akta.pro rank

Product category

POCT In Vitro Diagnostic Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391), In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Veterinary POCT & Rapid Diagnostics (Animal health rapid tests) (HLAHAOAL)

akta.pro secondary industries

Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI), Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate) (HLAHAOAB), Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer) (HLAHAOAC)

Keywords

• POCT diagnostic analyzers
• Microfluidic reagent discs
• Veterinary blood analyzers
• Clinical chemistry analyzers
• In vitro diagnostic devices

Headquarters

HQ city

Chengdu, Sichuan

HQ country

China

HQ region

Asia

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Veterinary Biochemical Analyzers and Reagent Discs: Veterinary biochemical analyzers (SMT-120VP, V7, Qt3, MiniLabVet) sold alongside proprietary reagent discs. Veterinary division covers pet hospitals, clinics, large animal (livestock) farms, and aquatic farms globally. Veterinary market coverage exceeds 40% in domestic China.
2. Medical Human-Use POCT Analyzers and Reagent Discs: Medical biochemical analyzers (SD1, SD2, SMT-120Pro, SG1) for human point-of-care testing. Targets primary care clinics, emergency departments, ICUs, and community health centers. Medical reagent discs include 40 test items in 39 combinations.
3. Consumables and Reagent Discs: Single-use reagent discs for both veterinary and medical analyzers. Discs use freeze-drying technology with 1-year shelf life at 2-8°C. Consumable revenue is recurring as instruments are installed in customer sites.
4. Molecular Diagnostics (PCR) Products: VQ1 all-in-one nucleic acid detection system for veterinary molecular testing. Closed microfluidic reagent cartridge pre-loaded with freeze-dried reagents enables 40-minute nucleic acid extraction, purification and qPCR.
5. Technical Support and After-sales Services: After-sales service including nationwide (China) touring maintenance teams covering 23 provinces and 283 cities, and global service in 80+ countries. 7×24 hour service commitment for customers.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Chengdu Seamaty Technology designs, manufactures, and sells Point-of-Care Testing (POCT) in vitro diagnostic analyzers paired with proprietary freeze-dried microfluidic reagent discs for both human medical and veterinary applications. The portfolio spans dry biochemistry, blood gas/electrolyte, chemiluminescence immunoassay, and qPCR nucleic acid testing systems, with each analyzer supported by sealed single-shot reagent discs that deliver multi-parameter results from a small blood sample within roughly 12 minutes.

Product overview

Seamaty (Chengdu Seamaty Technology Co., Ltd.) is a specialized POCT (Point-of-Care Testing) company offering a portfolio of dry biochemistry analyzers, blood gas electrolyte analyzers, chemiluminescence immunoassay analyzers, and molecular diagnostics products for both human medical and veterinary applications. The product lineup includes: SD1 and SD2 dry biochemistry analyzers (human medical) combining routine biochemistry, electrolyte, and coagulation testing; SMT-120Pro and SMT-120VP veterinary biochemistry analyzers covering 33 test parameters across 24 reagent disc combinations; V7 and Qt3 large-animal veterinary biochemistry analyzers with 41 test coverage; VG2 veterinary blood gas immune analyzer and MiniLabVet four-channel veterinary analyzer integrating biochemistry, fluorescent immunoassay, and blood gas electrolyte platforms; VQ1 fully automated nucleic acid (PCR) testing system; SMT-680/SMT-780 chemiluminescence immunoassay analyzers; SG1 blood gas electrolyte analyzer for human use; and a comprehensive range of reagent discs (39 types for medical, 13 types for veterinary) based on proprietary microfluidic and freeze-drying technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• SD1 Automatic Dry Biochemistry Analyzer Compact automatic dry biochemistry analyzer for point-of-care clinical chemistry testing in primary care and community clinic settings.
• SMT-120Pro Automatic Biochemistry Analyzer Automatic biochemistry analyzer delivering multi-parameter clinical chemistry panels at the point of care for clinics and hospital laboratories.
• SG1 Blood Gas Electrolyte Analyzer Point-of-care blood gas and electrolyte analyzer designed for emergency rooms, ICUs, and bedside critical-care testing.
• SD2 Automatic Microfluidic Dry Biochemistry Analyzer Automatic microfluidic dry biochemistry analyzer that uses Seamaty's freeze-dried reagent discs to deliver multi-parameter clinical chemistry results from a small sample.
• VG2 Veterinary Blood Gas Immune Analyzer Integrated veterinary analyzer combining blood gas and immune assay testing on a single device for pet hospitals and veterinary clinics.
• MiniLabVet Veterinary Four-Channel Analyzer Compact four-channel veterinary analyzer delivering rapid multi-parameter bloodwork for companion animal clinics.
• VQ1 Fully Automated Nucleic Acid Testing System Fully automated qPCR nucleic acid testing system integrating extraction and amplification for disease control centers, universities, and research laboratories.
• V7 Veterinary Automatic Biochemistry Analyzer Automatic biochemistry analyzer designed for veterinary clinical chemistry testing on companion animals and livestock.
• Qt3 Veterinary Automatic Biochemistry Analyzer Automatic biochemistry analyzer sized for veterinary point-of-care use, including smaller companion animal clinics.
• SMT-680 High-Throughput POCT Chemiluminescence Immunoassay Analyzer High-throughput chemiluminescence immunoassay analyzer using capillary chemiluminescence technology for hospital laboratories and clinical research applications.
• SMT-780 Fully Automatic Chemiluminescence Immunoassay Analyzer Fully automatic chemiluminescence immunoassay analyzer offering higher-throughput automated immunoassay testing for hospital and reference laboratory settings.
• Medical Biochemistry Reagent Disc Sealed, freeze-dried microfluidic reagent disc consumable used with Seamaty's medical dry biochemistry analyzers to deliver multi-parameter clinical chemistry panels from a single sample.
• Veterinary Biochemistry Reagent Disc Sealed, freeze-dried microfluidic reagent disc consumable used with Seamaty's veterinary biochemistry analyzers to deliver multi-parameter animal bloodwork from a single sample.

Quantifiable outcome

• 40% market share in domestic Chinese pet hospital market
• +4 more outcomes

Named customers16 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Singapore SPCAcoreStrategic or Co-development Partner · 11 March 2025Seamaty partnered with Singapore SPCA non-profit community animal clinic by providing veterinary biochemical analyzer, hematology analyzer, and immune blood gas analyzer free of charge. The clinic serves strays and rescue animals with subsidized care. Seamaty's equipment enables rapid, accurate diagnosis helping the clinic reduce operating costs and focus resources on animal rescue. Partnership supports SPCA's annual ~SGD 4 million operating expenses.
• Sichuan UniversitycoreStrategic or Co-development Partner · 19 November 2024Sichuan University and Seamaty signed a RMB 5 million (500万) scientific research cooperation agreement for joint development of high-performance biosensors. Professor Xiao Dan from Sichuan University's top biosensing research team leads the academic side. The partnership covers talent development, academic exchange, joint research, and technology commercialization. This represents a strategic R&D collaboration leveraging Sichuan University's academic excellence with Seamaty's industrial capabilities.
• Southeast Asian Veterinary DelegationcoreGTM or Marketing Partner · 3 September 2024Following WSAVA 2024 World Congress, Seamaty hosted a Southeast Asian veterinary delegation at its Chengdu headquarters for deep engagement. Delegates included veterinary professionals and industry leaders from Southeast Asia. The visit included company tour, strategy presentation, customer appreciation dinner, and smart factory tour. CEO Ran Peng emphasized shared commitment to advancing global veterinary innovation.
• Aristotle University of Thessaloniki (Greece)coreStrategic or Co-development Partner · 9 May 2023Veterinary School of Aristotle University of Thessaloniki uses SMT-120VP in its anesthesia and critical care unit. The device provides rapid, reliable results essential for emergency services and student practical training. Professor Savvas Loannis praised Seamaty's software upgrade support and technical backing. University selected Seamaty based on three factors: reliability, technical support, and price.
• Dokuz Eylul University Veterinary Faculty (Turkey)minorStrategic or Co-development Partner · 8 October 2022Dokuz Eylul University veterinary faculty in Izmir, Turkey received SMT-120VP donation through Seamaty's Turkish subsidiary. The equipment is used for laboratory research and wildlife rescue operations. Dean Prof. Victory Cloud noted the device suits their diverse teaching needs for both clinical and wildlife conservation applications.
• Mahasarakham University (Thailand)coreStrategic or Co-development Partner · 31 May 2022Seamaty Thailand subsidiary signed strategic cooperation with Mahasarakham University veterinary faculty. MSU previously used IDEXX equipment but found Seamaty SMT-120VP more accurate, easier to use, and cost-effective. The partnership provides teaching facilities for animal medicine program and supports培养更多全面技能型人才. Veterinary hospitals at Khamriang campus use Seamaty equipment for clinical and research applications.
• Jilin Agricultural University (China)minorStrategic or Co-development Partner · 17 November 2020Seamaty donated 3 SMT-120V veterinary biochemical analyzers to Jilin Agricultural University Animal Science and Veterinary Medicine College. The donation supports animal medicine discipline development and provides practical training equipment for students. Northeast regional sales manager Bai Xue represented Seamaty at the donation ceremony.

Scale indicators13 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• Woodley Equipment: UK-based veterinary diagnostics distributor and equipment provider offering in-clinic chemistry and hematology analyzers. Comparable focus on vet POCT equipment, particularly in European and emerging markets.
• Heska (Mars Petcare): Veterinary diagnostics specialist acquired by Mars Petcare; offers point-of-care chemistry, hematology, and immunoassay analyzers. Highly comparable product overlap with Seamaty's vet POCT analyzer and reagent disc portfolio.
• Edan Instruments: China-based medical device maker with POCT and patient-monitoring product lines. Comparable Chinese-origin POCT peer targeting similar primary-care and emerging-market channels.
• Zoetis: Animal health giant whose Vetscan line of in-clinic diagnostic analyzers competes head-to-head with Seamaty's SMT-120VP and V7 veterinary biochemistry analyzers. Zoetis brings stronger distribution and brand in companion-animal practice.
• Snibe (Shenzhen New Industries Biomedical Engineering): Chinese IVD leader specializing in chemiluminescence immunoassay analyzers (Maglumi series), directly comparable to Seamaty's SMT-680/SMT-780 capillary chemiluminescence platform. Same Chinese origin and similar export-driven growth model.
• IDEXX Laboratories: Global leader in veterinary diagnostics with IDEXX VetLab in-clinic analyzers and reference-lab services. Direct competitor to Seamaty in the vet POCT category, particularly in mature Western clinics where IDEXX's bundled consumables and reference network dominate.
• Mindray: China-based global medical device leader with substantial POCT and IVD product lines, including veterinary offerings. Comparable Chinese-origin POCT competitor with broader scale and a more developed human-side franchise.

Broad incumbents

• QuidelOrtho: Broader in-vitro diagnostics incumbent with a strong POCT franchise (e.g., Sofia, Triage) spanning immunoassay and rapid testing. Competes with Seamaty more on the medical/immunoassay side than in veterinary.
• Abbott Point of Care: Global diagnostics incumbent whose i-STAT system is the dominant handheld blood gas and chemistry analyzer in hospital and emergency settings. Direct overlap with Seamaty's SG1 and SD1 medical product lines.

Emerging players

• Randox: UK-headquartered diagnostics company with extensive clinical chemistry and immunoassay menus for centralized and point-of-care use. Comparable as a multi-modality diagnostics challenger to the global incumbents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/chengdu-seamaty-technology-co-ltd

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chengdu Seamaty Technology Co., Ltd